Relationship between magnesium and lipids in patients with diabetes mellitus

References

• Omran AR. The epidemiologic transition: a theory of the epidemiology of population change. Milbank Q. 2005;83(4):731–757. doi: 10.1111/j.1468-0009.2005.00398.x
   PubMed Web of Science ®Google Scholar
• World Health Organization. Global status report on noncommunicable diseases 2014 [document on the Internet]. Geneva: World Health Organization; 2014. Available from: http://apps.who.int/iris/bitstream/10665/148114/1/9789241564854_eng.pdf?ua=1.
   Google Scholar
• Boden WE. High-density lipoprotein cholesterol as an independent risk factor in cardiovascular disease: assessing the data from Framingham to the veterans affairs high--density lipoprotein intervention trial. Am J Cardiol. 2000;86(12A):19–22. doi: 10.1016/S0002-9149(00)01464-8
   PubMed Web of Science ®Google Scholar
• Howard BV, Robbins DC, Sievers ML, et al. LDL cholesterol as a strong predictor of coronary heart disease in diabetic individuals with insulin resistance and low LDL: the strong heart study. Arterioscler Thromb Vasc Biol. 2000;20(3):830–835. doi: 10.1161/01.ATV.20.3.830
   PubMed Web of Science ®Google Scholar
• Miller M, Stone NJ, Ballantyne C, et al. Triglycerides and cardiovascular disease: a scientific statement from the American Heart Association. Circ. 2011;123(20):2292–2333. doi: 10.1161/CIR.0b013e3182160726
   PubMed Web of Science ®Google Scholar
• Huang JH, Lu YF, Cheng FC, et al. Correlation of magnesium intake with metabolic parameters, depression and physical activity in elderly type 2 diabetes patients: a cross-sectional study. Nutr J. 2012;11:41. doi: 10.1186/1475-2891-11-41
   PubMed Web of Science ®Google Scholar
• Rasheed H, Elahi S, Ajaz H. Serum magnesium and atherogenic lipid fractions in type II diabetic patients of Lahore, Pakistan. Biol Trace Elem Res. 2012;148(2):165–169. doi: 10.1007/s12011-012-9361-5
   PubMed Web of Science ®Google Scholar
• Cao Y, Wang C, Guan K, et al. Association of magnesium in serum and urine with carotid intima-media thickness and serum lipids in middle-aged and elderly Chinese: a community-based cross-sectional study. Eur J Nutr. 2016;55(1):219–226. doi: 10.1007/s00394-015-0839-8
   PubMed Web of Science ®Google Scholar
• Mirmiran P, Shab-Bidar S, Hosseini-Esfahani F, et al. Magnesium intake and prevalence of metabolic syndrome in adults: Tehran lipid and glucose study. Public Health Nutr. 2012;15(4):693–701. doi: 10.1017/S1368980011002941
   PubMed Web of Science ®Google Scholar
• Verma H, Garg R. Effect of magnesium supplementation on type 2 diabetes associated cardiovascular risk factors: a systematic review and meta-analysis. J Hum Nutr Diet. 2017;30(5):621–633. doi: 10.1111/jhn.12454
   PubMed Web of Science ®Google Scholar
• Palacios C, Wigertz K, Braun M, et al. Magnesium retention from metabolic-balance studies in female adolescents: impact of race, dietary salt, and calcium. Am J Clin Nutr. 2013;97(5):1014–1019. doi: 10.3945/ajcn.112.039867
   PubMed Web of Science ®Google Scholar
• Wang L, Sacks FM, Furtado JD, et al. Racial differences between African-American and white women in insulin resistance and visceral adiposity are associated with differences in apoCIII containing apoAI and apoB lipoproteins. Nutr Metab. 2014;11(1):56. doi: 10.1186/1743-7075-11-56
   Google Scholar
• Pillay S, Aldous C. Introducing a multifaceted approach to the management of diabetes mellitus in resource-limited settings. S Afr Med J. 2016;106(5):42–43.
   PubMed Web of Science ®Google Scholar
• Klug E. South African dyslipidaemia guideline consensus statement. S Afr Med J. 2012;102(3 Pt 2):178–187. doi: 10.7196/SAMJ.5502
   PubMed Web of Science ®Google Scholar
• Amod A, Motala A, Levitt N, et al. The 2012 SEMDSA guideline for the management of type 2 diabetes. J Endocrinol Metab Diab S Afr. 2012;17(1):S1–S94.
   Google Scholar
• Kao WH, Folsom AR, Nieto FJ, et al. Serum and dietary magnesium and the risk for type 2 diabetes mellitus: the atherosclerosis risk in communities study. Arch Intern Med. 1999;159(18):2151–2159. doi: 10.1001/archinte.159.18.2151
   PubMedGoogle Scholar
• Nanri A, Mizoue T, Noda M, et al. Magnesium intake and type II diabetes in Japanese men and women: the Japan public health center-based prospective study. Eur J Clin Nutr. 2010;64(10):1244–1247. doi: 10.1038/ejcn.2010.138
   PubMed Web of Science ®Google Scholar
• Punyadeera C, van der Merwe MT, Crowther NJ, et al. Ethnic differences in lipid metabolism in two groups of obese South African women. J Lipid Res. 2001;42(5):760–767.
   PubMed Web of Science ®Google Scholar
• Wajchenberg BL. Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome. Endocr Rev. 2000;21(6):697–738. doi: 10.1210/edrv.21.6.0415
   PubMed Web of Science ®Google Scholar
• Einstein FH, Atzmon G, Yang XM, et al. Differential responses of visceral and subcutaneous fat depots to nutrients. Diab. 2005;54(3):672–678. doi: 10.2337/diabetes.54.3.672
   PubMed Web of Science ®Google Scholar
• Rosanoff A, Seelig MS. Comparison of mechanism and functional effects of magnesium and statin pharmaceuticals. J Am Coll Nutr. 2004;23(5):501S–505S. doi: 10.1080/07315724.2004.10719389
   PubMed Web of Science ®Google Scholar
• Popkin BM, Adair LS, Ng SW. Global nutrition transition and the pandemic of obesity in developing countries. Nutr Rev. 2012;70(1):3–21. doi: 10.1111/j.1753-4887.2011.00456.x
   PubMed Web of Science ®Google Scholar
• Misra A, Khurana L. Obesity and the metabolic syndrome in developing countries. J Clin Endocrinol Metab. 2008;93(11_supp_1):s9–s30. https://doi.org/10.1210/jc.2008-1595
   PubMed Web of Science ®Google Scholar